Establishment Labs Holdings Inc.
NASDAQ:ESTAMedical - Devices
+$2.65 today
- Market cap
- $2.11B
- Beta
- 1.11
- P/E (TTM)
- -57.6
- EPS (TTM)
- -$1.48
Volume 0.38M
Average 0.50M
ESTA Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
Establishment Labs Holdings Inc.NASDAQ: ESTA
Operating Margin · Q3 FY2026 · quarter ended Sep 2026
Operating margin widens to -3.6%
Operating margin was -3.6% in Q3 FY2026, up 3.8 pp from a year earlier. On a trailing-twelve-month basis it was -6.6%, up 21.6 pp year over year. Over 3 fiscal years it widened by 6.0 pp.
Context
- Operating margin widened in 2 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether operating margin reaches the consensus estimate from 7 analysts of -7.3% for the fiscal year ending Dec 2026, up from -18.5% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- -3.6%+2.7 pp QoQ
- Last fiscal yearDec 2025
- -18.5%+11.6 pp YoY
- LTMSep 2026
- -6.6%+21.6 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +3.8 pp | +7.7 pp | +3.9 pp |
| 1 year | +11.6 pp | +11.2 pp | -0.4 pp |
| 3 years | +6.0 pp | +34.4 pp | +28.3 pp |
| 5 years | +36.2 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -18.5%
- Year-over-year change
- +11.6pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -18.5% | +11.6pp |
| FY2024 | 2024-12-31 | -30.1% | +9.3pp |
| FY2023 | 2023-12-31 | -39.4% | -14.8pp |
| FY2022 | 2022-12-31 | -24.5% | -4.7pp |
| FY2021 | 2021-12-31 | -19.8% | — |
Operating Margin vs competitors
How ESTA compares with its peers on the latest reported figures
- ESTA's LTM Sep 2026 operating margin of -6.6% is the 3rd highest of the 4 companies compared; the peer median is 7.5%.
- Its year-over-year change of +21.6 pp is the highest of 4, against a peer median of +6.9 pp.
- Over three fiscal years its change of +6.0 pp compares with a peer median of -11.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 21.3% | -6.7 pp | -20.5 pp | |
| LTM Mar 2026 | 7.5% | +7.0 pp | -11.2 pp | |
| LTM Sep 2026 | -6.6% | +21.6 pp | +6.0 pp | |
| LTM Jun 2026 | -42.6% | +6.9 pp | +52.1 pp | |
| Peer median (excluding ESTA) | 7.5% | +6.9 pp | -11.2 pp | |
Competitors are the stored peer set for ESTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 126.68M | 161.7M | 165.15M | 166.03M | 211.08M |
| Cost of Revenue | 41.28M | 55.11M | 58.17M | 56.5M | 64.77M |
| Gross Profit | 85.4M | 106.6M | 106.98M | 109.53M | 146.31M |
| Gross Margin | 67.4% | 65.9% | 64.8% | 66.0% | 69.3% |
| Research & Development | 18.32M | 20.27M | 26.43M | 19.71M | 20.25M |
| Selling, General & Admin | 92.23M | 125.98M | 145.58M | 139.81M | 165.07M |
| Operating Expenses | 110.54M | 146.25M | 172M | 159.51M | 185.32M |
| Depreciation & Amortization | 4.12M | 4.34M | 4.88M | 7.58M | 10.47M |
| EBITDA | (26.53M) | (56.73M) | (58.31M) | (56.22M) | (22.29M) |
| EBITDA Margin | -20.9% | -35.1% | -35.3% | -33.9% | -10.6% |
| Operating Income | (25.14M) | (39.66M) | (65.03M) | (49.99M) | (39.01M) |
| Operating Margin | -19.8% | -24.5% | -39.4% | -30.1% | -18.5% |
| Interest Income | 23K | 87K | 1.02M | 1.48M | 423K |
| Interest Expense | 9.06M | 11.76M | 15.39M | 20.83M | 25.26M |
| Other Income / Expenses | (14.57M) | (33.17M) | (13.56M) | (34.64M) | (19.01M) |
| Income Before Tax | (39.71M) | (72.82M) | (78.58M) | (84.63M) | (58.02M) |
| Pre-Tax Margin | -31.3% | -45.0% | -47.6% | -51.0% | -27.5% |
| Income Tax Expense | 1.43M | 2.39M | (81K) | (32K) | (6.96M) |
| Net Income | (41.14M) | (75.21M) | (78.5M) | (84.6M) | (51.06M) |
| Net Margin | -32.5% | -46.5% | -47.5% | -51.0% | -24.2% |
| EPS (Basic) | (1.72) | (3.08) | (3.07) | (3.00) | (1.72) |
| EPS (Diluted) | (1.72) | (3.08) | (3.07) | (3.00) | (1.72) |
| Weighted Avg Shares | 23.97M | 24.46M | 25.6M | 28.16M | 29.62M |
| Weighted Avg Shares (Diluted) | 23.97M | 24.46M | 25.6M | 28.16M | 29.62M |
Establishment Labs Holdings Inc.
NASDAQ:ESTA
Intrinsic Alpha fair value
Locked
Current Price
$70.80
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.